These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2082904)

  • 1. Practical drug therapy for common hyperlipidaemias.
    Tikkanen MJ
    Baillieres Clin Endocrinol Metab; 1990 Dec; 4(4):719-42. PubMed ID: 2082904
    [No Abstract]   [Full Text] [Related]  

  • 2. Currently available lipid-lowering agents.
    Levy RI
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():14-21. PubMed ID: 3134381
    [No Abstract]   [Full Text] [Related]  

  • 3. [Overviews of fibrate].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating lipid disorders.
    Manninen V; Mälkönen M; Tuomilehto J
    Am Heart J; 1979 May; 97(5):674-6. PubMed ID: 219673
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary prevention of coronary heart disease: where do we go from here?
    Gotto AM
    Arch Intern Med; 2001 Apr; 161(7):922-4. PubMed ID: 11295953
    [No Abstract]   [Full Text] [Related]  

  • 6. [Gemfibrozil: new aspects in clinical use].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():625-30. PubMed ID: 11347143
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of coronary heart disease by therapy of hyperlipidemia. Between cholesterol hysteria and therapeutic realism].
    Deller M; Huth K
    Fortschr Med; 1992 Sep; 110(25):463-6. PubMed ID: 1398397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [KLAS [Kanazawa Lipid Assessment Survey]].
    Mabuchi H; Inazu A; Higashikata T; Nohara A; Koizumi J
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():469-76. PubMed ID: 11347115
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination lipid-altering therapy: an emerging treatment paradigm for the 21st century.
    Jacobson TA
    Curr Atheroscler Rep; 2001 Sep; 3(5):373-82. PubMed ID: 11487448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Helsinki Heart Study].
    Sekiya M; Ishibashi S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():404-9. PubMed ID: 11347103
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperlipidemia in the elderly].
    Kawano M
    Nihon Rinsho; 2002 May; 60(5):1017-23. PubMed ID: 12029980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of new lipotropic preparations in hyperlipemia].
    Miasnikov LA; Bavina MV; Lobova NM; Koropova GI
    Kardiologiia; 1971 Aug; 11(8):26-30. PubMed ID: 5160871
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperlipidemia. What to do when life-style changes aren't enough.
    Peters WL
    Postgrad Med; 1991 Oct; 90(5):213-7, 220-4. PubMed ID: 1924009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of dyslipidemia.
    McKenney JM
    Cardiovasc Drugs Ther; 2001 Sep; 15(5):413-22. PubMed ID: 11855660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A head-to-head comparison of the cost effectiveness of HMG-CoA reductase inhibitors and fibrates in different types of primary hyperlipidemia.
    Perreault S; Hamilton VH; Lavoie F; Grover S
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):787-94. PubMed ID: 9110123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic management of the dyslipidemic patient].
    Agence Française de Sécurité Sanitaire des Produits de Santé
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):70-5. PubMed ID: 11240406
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of blood lipid abnormalities in coronary heart disease patients.
    Kuo PT
    Clin Cardiol; 1989 Oct; 12(10):553-60. PubMed ID: 2680196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid disorders in NIDDM: implications for treatment.
    Taskinen MR; Smith U
    J Intern Med; 1998 Nov; 244(5):361-70. PubMed ID: 9845851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention of ischaemic heart disease with lipid-lowering drugs.
    Lancet; 1988 Feb; 1(8581):333-4. PubMed ID: 2893141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.